Interferon-alpha inhibits chromogranin A promoter activity in neuroendocrine pancreatic cancer cells.

about

Interferon-alpha inhibits chromogranin A promoter activity in neuroendocrine pancreatic cancer cells.

Item

http://www.wikidata.org/entity/Q42480221

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

1999年论文

@zh

1999年论文

@zh-cn

name

Interferon-alpha inhibits chro ...... crine pancreatic cancer cells.

@en

Interferon-alpha inhibits chro ...... crine pancreatic cancer cells.

@nl

type

Item

label

Interferon-alpha inhibits chro ...... crine pancreatic cancer cells.

@en

Interferon-alpha inhibits chro ...... crine pancreatic cancer cells.

@nl

prefLabel

Interferon-alpha inhibits chro ...... crine pancreatic cancer cells.

@en

Interferon-alpha inhibits chro ...... crine pancreatic cancer cells.

@nl

P1476

Interferon-alpha inhibits chro ...... crine pancreatic cancer cells.

@en

P2093

B Wiedenmann

http://www.w3.org/2001/XMLSchema#string

E O Riecken

http://www.w3.org/2001/XMLSchema#string

M Höcker

http://www.w3.org/2001/XMLSchema#string

S Rosewicz

http://www.w3.org/2001/XMLSchema#string

T C Wang

http://www.w3.org/2001/XMLSchema#string

T Plath

http://www.w3.org/2001/XMLSchema#string

P2860

Chromogranin A: current status as a precursor for bioactive peptides and a granulogenic/sorting factor in the regulated secretory pathway

Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha

STATs and gene regulation

A functional cyclic AMP response element plays a crucial role in neuroendocrine cell type-specific expression of the secretory granule protein chromogranin A.

Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300.

Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes.

Biogenesis of secretory granules and synaptic vesicles. Facts and hypotheses.

Metastatic carcinoid tumors and the malignant carcinoid syndrome.

Treatment of carcinoid syndrome with recombinant interferon alpha-2a.

Molecular and cell biological aspects of neuroendocrine tumors of the gastroenteropancreatic system.

P304

378-382

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0014-5793(99)01187-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

458

http://www.w3.org/2001/XMLSchema#string

P577

1999-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10570944

http://www.w3.org/2001/XMLSchema#string